Recruiting Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) NCT04924075 Conditions Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more Locations Cedars-Sinai Medical Center ( Site 0110) — Los Angeles, California, United States Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) — Chicago, Illinois, United States Northwestern Medicine Cancer Center - Warrenville ( Site 0134) — Warrenville, Illinois, United States University of Iowa ( Site 0104) — Iowa City, Iowa, United States View all 84 locations View more locations Show fewer locations Loading locations... View Trial Details
